Crinetics Pharmaceuticals
CRNX
CRNX
118 hedge funds and large institutions have $1.26B invested in Crinetics Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
26% more funds holding
Funds holding: 94 → 118 (+24)
5.99% more ownership
Funds ownership: 87.22% → 93.21% (+6%)
Holders
118
Holding in Top 10
9
Calls
$2K
Puts
–
Top Buyers
1 | +$58.2M | |
2 | +$51M | |
3 | +$34.1M | |
4 |
BlackRock
New York
|
+$18.7M |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.6M |
Top Sellers
1 | -$20M | |
2 | -$14.2M | |
3 | -$11.7M | |
4 |
VC
Vivo Capital
Palo Alto,
California
|
-$10.9M |
5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.56M |